Testing effectiveness (Phase 2)Ended earlyNCT03795233What this trial is testingFecal Microbiota Transplant for Primary CDIWho this might be right forClostridium Difficile Infection Boston Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT01232595What this trial is testingSafety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile InfectionsWho this might be right forModerate Clostridium Difficile Infection Novartis Pharmaceuticals 109
Not applicableStudy completedNCT00004363What this trial is testingStudy of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes InsipidusWho this might be right forDiabetes InsipidusDiabetes Insipidus, Neurohypophyseal National Center for Research Resources (NCRR)
Not applicableUnknownNCT03964844What this trial is testingClostridium Difficile Infection (CDI) in Hematologic Patients.Who this might be right forC.Difficile Diarrhea Hospital General Universitario Gregorio Marañon 450
Post-approval studies (Phase 4)WithdrawnNCT04241744What this trial is testingProspective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDIWho this might be right forCDI Creighton University
Large-scale testing (Phase 3)Study completedNCT02254811What this trial is testingFMT Delivered by Capsule Versus Colonoscopy for Recurrent C. DiffWho this might be right forEnterocolitis Clostridium Difficile Recurrent University of Alberta 116
Large-scale testing (Phase 3)UnknownNCT06107569What this trial is testingTreatment of CDI and Recurrence With Fecal Microbiota Transplant Using PromicrobiomaWho this might be right forClostridium Difficile Infections Hospital Universitario Evangelico de Curitiba 24
Not applicableLooking for participantsNCT06742060What this trial is testingThe Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICUWho this might be right forDiabetes Insipidus, NeurohypophysealCopeptin Blood LevelsCopeptin+1 more Children's Hospital of Fudan University 100
Early research (Phase 1)Study completedNCT02830542What this trial is testingSER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent RecurrenceWho this might be right forClostridium Difficile Infection Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02299570What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionWho this might be right forEnterocolitis Clostridium Difficile Recurrent Rebiotix Inc. 150
Not applicableWithdrawnNCT02968511What this trial is testingEGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota TransplantWho this might be right forC.Difficile Colitis Milton S. Hershey Medical Center
Not applicableStudy completedNCT04014608What this trial is testingProtocol for Admission Toxigenic C. Difficile SurveillanceWho this might be right forClostridium Difficile Infection Endeavor Health 148,549
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461What this trial is testingA Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.Who this might be right forIrritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more PharmaPlanter Technologies Inc 63
Post-approval studies (Phase 4)Study completedNCT03880539What this trial is testingBezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence University of Kansas Medical Center 4
Early research (Phase 1)Study completedNCT02865616What this trial is testingMET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)Who this might be right forClostridium Difficile Infection NuBiyota 19
Not applicableStudy completedNCT02461901What this trial is testingDoes Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?Who this might be right forClostridium Difficile Infection Professor Mark Wilcox 203
Large-scale testing (Phase 3)Study completedNCT01241552What this trial is testingMK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)Who this might be right forClostridium Difficile Infection Merck Sharp & Dohme LLC 1,452
Testing effectiveness (Phase 2)Study completedNCT03353506What this trial is testingLyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff InfectionWho this might be right forEnterocolitisRecurrent Clostridium Difficile Infection Dina Kao 11
Not applicableStudy completedNCT02223715What this trial is testingProspective Observational Study of Clostridium Difficile Infection in Asian Pacific CountriesWho this might be right forClostridium Difficile Infection Otsuka Pharmaceutical Co., Ltd. 600
Testing effectiveness (Phase 2)Ended earlyNCT06536465What this trial is testingThe Clostridioides Difficile Trial of REC-3964Who this might be right forRecurrent Clostridioides Difficile Infection Recursion Pharmaceuticals Inc. 3